Laboratory issues in gene therapy and emicizumab

ePaper
Share:

Effects of Emicizumab on APTT FVIII assays and FVIII

ePaper
Share:
Print | Sitemap

UK NEQAS for Blood Coagulation programmes are hosted by the Sheffield Teaching Hospitals NHS Foundation Trust. We are a UKAS accredited proficiency testing provider (BS EN ISO/IEC 17043:2010).
Terms and Conditions
Privacy Policy

Participant Login
Facebook
Twitter

© UK NEQAS FOR BLOOD COAGULATION

Call

E-mail

Directions